Search - tctmd.com

Displaying 121 - 140 of 371

Sort: Relevancy | Date

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

News Conference News ACC 2024

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

L.A. McKeown

April 12, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Todd Neale

March 25, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

Presentation THT 2024

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Presenter: Sean P. Pinney

March 06, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Presenter: Gilad Marom

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Vsling- Ventricular repair device for HFrEF patients

Presenter: Boaz Manash

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

Advertisement

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Statins Might Help in HFpEF—Even in the Absence of ASCVD

TCTMD’s Top 10 Most Popular Stories for April 2024

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Vsling- Ventricular repair device for HFrEF patients

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

March 2024 Dispatch for the CV Team

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content